“Histone H3 lysine 9 trimethylation and HP1γ favor inclusion of alternative exons.”
Saint-André V, Batsché E, Rachez C, Muchardt C.
Nat Struct Mol Biol. 2011 Mar;18(3):337-44. Epub 2011 Feb 27.
Categories: Article
Article
In J Exp Clin Cancer Res: Splicing targeting drugs highlight intron retention as an actionable vulnerability in advanced prostate cancer
Splicing targeting drugs highlight intron retention as an actionable vulnerability in advanced prostate cancer Chiara Naro, Ambra Antonioni, Vanessa Medici, Cinzia Caggiano, Ariane Jolly, Pierre de la Grange, Pamela Bielli, Maria Paola Paronetto, Claudio Sette Read more…